Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7973

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-7973). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

This text provides information on the hazard ratio (HR) of 0.56 with a 95% confidence interval of 0.46-0.69, and a significant p-value of less than 0.001. Additionally, it shows the cumulative incidence in percentage for two groups (Rosuvastatin and Placebo) with the number at risk indicated for each time point. This data can be used in statistical analysis and clinical studies.*

FDA Label Image

Figure2 (Image 01)

This is a statistical evaluation comparing the effects of Rosuvastatin 20 mg versus placebo on various endpoints. The Hazard Ratios with 95% confidence intervals and p-values are presented for primary endpoints (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization. The results show significant risk reduction in primary endpoint (MCE) and other events favoring the Rosuvastatin group.*

FDA Label Image

Figure3 (Image 02)

This text is not readable.*

FDA Label Image

Label Image (Lbl500907973)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.